6BA Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032
P. Chapman, I. Puzanov, J. Sosman, K. Kim, A. Ribas, G. McArthur, R. Lee, J. Grippo, K. Nolop, K. FlahertyVolume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)72036-1
File:
PDF, 50 KB
english, 2009